...
首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Progression of romiplostim myelofibrosis to myeloproliferative neoplasm
【24h】

Progression of romiplostim myelofibrosis to myeloproliferative neoplasm

机译:romiplostim骨髓纤维化进展为骨髓增生性肿瘤

获取原文
获取原文并翻译 | 示例

摘要

A 65-year-old man received a diagnosis of idiopathic thrombocytopenic purpura (FTP) 2 years ago based on an isolated thrornbocytopenia (55 X 103/|xL); however, bone marrow showed only increased megakaryocytes, including naked ones (panel A), and cytogenetic studies were unremarkable. The patient failed improvement with steroids, intravenous immunoglobulin, and Rituxan therapy. Also, romiplostim therapy was administered weekly for 4 weeks without improvement. Repeat bone marrow during romiplostim treatment showed hypercellular marrow with 60% to 70% cellularity with increased megakaryocytes and 3/4 reticulin fibrosis (panel B). Repeat marrow was done after the patient was off romiplostim for 6 weeks.. The marrow showed progression of the process to a picture of myelodysplastic/myeloproliferative neoplasms (MDS/MPN) with cellularity of 90% with dysplastic megakaryocytes, granulocytosis/ myeloid hyperplasia, and 4/4 reticulin fibrosis (panel C). The blood shows leukoerythroblastosis, Pelgeroid polymorphonuclear neutrophils, and blasts (5%) (panel D).
机译:一名65岁的男性2年前根据孤立的血小板减少症(55 X 103 / | xL)被诊断出特发性血小板减少性紫癜(FTP);然而,骨髓仅显示了巨核细胞的增加,包括裸核(图A),并且细胞遗传学研究并不显着。患者使用类固醇,静脉注射免疫球蛋白和利妥昔单抗治疗均未能改善。同样,每周接受romiplostim治疗,持续4周,但无改善。 romiplostim治疗期间重复骨髓显示,高细胞性骨髓细胞具有60%至70%的细胞性,巨核细胞增多和3/4网状蛋白纤维化(面板B)。患者从romiplostim停用6周后重复进行骨髓。骨髓显示过程进展为骨髓增生异常/骨髓增生性肿瘤(MDS / MPN),细胞增生率为90%,发育异常的巨核细胞,粒细胞增多/髓样增生,以及4/4网状蛋白纤维化(图C)。血液显示白细胞成纤维细胞增多症,多形性中性粒细胞中性粒细胞和母细胞(5%)(图D)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号